CVRdatabase
Menu

PharmaAConsultancy ApS

Private limited companyCVR 42788341København NVActive

PharmaAConsultancy ApS is a private limited company, based in København NV, active in other education n.e.c., founded in 2021. The company made a loss in both 2024 and 2025, most recently DKK 81,144. Equity fell to DKK 7,542 in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 59,301−87.9% vs. 2024
Net profit−DKK 81,144+31.9% vs. 2024
EquityDKK 7,542−91.5% vs. 2024
Employees2latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 95% (2024 → 2025), to DKK 14,561.
  • Revenue fell 88% (2024 → 2025), to DKK 59,301.
  • The loss got smaller: from DKK 119k to DKK 81,144 (2024 → 2025).
  • Equity fell 92% (2024 → 2025), to DKK 7,542.

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2022–2025 · amounts in DKK thousand

Equity and net profit

−DKK 150k−DKK 100k−DKK 50,000DKK 0DKK 50,000DKK 100kDKK 150kDKK 200k2022202320242025
EquityNet profit
Financial figures for PharmaAConsultancy ApS
2022202320242025Change
Revenue7422048859−87.9%
Gross profit3917829715−95.1%
Operating profit (EBIT)39178−120−81+32.1%
Profit before tax39174−119−81+31.9%
Net profit31136−119−81+31.9%
Total assets9226427948−82.9%
Equity73208898−91.5%
Liabilities195619040−78.9%
Cash and cash equivalents922152170−100%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 200kDKK 400kDKK 600kDKK 800kDKK 1mDKK 1.2mDKK 1.4m2022202320242025
Gross profitMedian, the industry (340 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Loss for 2 years in a row

    Net result has been negative in 2024–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

  • Equity fell sharply

    Equity fell 92% from 2024 to 2025 (DKK 88,798 to DKK 7,542).

    How is this calculated?

    Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

4 financial years
Annual reports for PharmaAConsultancy ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202526/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202413/05/2025The companyPDF not statedXBRL
202301/01/2023 – 31/12/202327/05/2024The companyPDF not statedXBRL
202226/10/2021 – 31/12/202227/05/2023The companyPDF not statedXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Position in the industry

340 companies in the database

Comparison with the other companies in other education n.e.c. based on the latest financial year.

Gross profitDKK 14,561No. 315 of 340
Better than 7% of the companies in the industry
EquityDKK 7,542No. 275 of 340
Better than 19% of the companies in the industry
Number of employees2No. 130 of 340
Better than 62% of the companies in the industry

Industry median: gross profit DKK 1.3m, net profit DKK 92,192, equity DKK 396k, 2 employees.

DKK 100kDKK 641kDKK 4.1mDKK 26.4mDKK 91m
Distribution of gross profit for 316 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 62,441of 69,742
Better than 10%
No. 59,614of 69,964
Better than 15%
Same industry and fewer than 20 employees306 companies in the comparison
No. 281of 306
Better than 8%
No. 244of 306
Better than 20%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 30,845of 33,588
Better than 8%
No. 28,180of 33,687
Better than 16%
All companies of type ApS66,508 companies in the comparison
No. 60,013of 66,379
Better than 10%
No. 55,915of 66,505
Better than 16%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Other education n.e.c.
Gross profit
  1. PharmaAConsultancy ApSDKK 14,561
  2. Ucplus A/SDKK 169.1m
  3. Forsikrings- og Pensionsakademiet A/SDKK 109.4m
Net profit
  1. PharmaAConsultancy ApS−DKK 81,144
  2. Ucplus A/SDKK 2.4m
  3. Forsikrings- og Pensionsakademiet A/S−DKK 864k
Equity
  1. PharmaAConsultancy ApSDKK 7,542
  2. Ucplus A/SDKK 26.7m
  3. Forsikrings- og Pensionsakademiet A/SDKK 95.5m
Employees
  1. PharmaAConsultancy ApS2
  2. Ucplus A/S378
  3. Forsikrings- og Pensionsakademiet A/S245

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Khalid Essam Abdel-Raouf Amar50%
  • Hashmatullah Nasimi50%
PharmaAConsultancy ApS

Management

2 active registrations

Executive management

Executive management at PharmaAConsultancy ApS
NameRoleAppointed
Khalid Essam Abdel-Raouf AmarDirector26/10/2021
Hashmatullah NasimiCEO27/10/2021
Founders
Khalid Essam Abdel-Raouf Amar, Hashmatullah Nasimi
Former management (1)
Former management at PharmaAConsultancy ApS
NameRoleAppointedResigned
Hashmatullah NasimiDirector26/10/202126/10/2021

Signing rule: Selskabet tegnes af den administrerende direktør.

Address and production units

1 active production units

Vibevej 49
2400 København NV

København Municipality · Postcode 2400

Production units
Production unitAddressEmployeesP number
PharmaAConsultancy ApSVibevej 49, 2. tv, 2400 København NV21027669642

Purpose

Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.

The purpose is quoted from the register in Danish.

Changes year by year

13 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20251 changeaccounts 1
  • Annual report for 2024 published
20241 changeaccounts 1
  • Annual report for 2023 published
20231 changeaccounts 1
  • Annual report for 2022 published
20222 changesaddress 2
  • Moved to Vibevej 49, 2. tv, 2400 København NV
  • Moved to Møntmestervej 22, 2. tv, 2400 København NV
20217 changesmanagement 4 · founded 1 · ownership 2
  • Hashmatullah Nasimi appointed ceo
  • Registered as PharmaAConsultancy ApS
  • Hashmatullah Nasimi appointed director
  • Hashmatullah Nasimi stepped down as director
  • Khalid Essam Abdel-Raouf Amar appointed director
  • Khalid Essam Abdel-Raouf Amar registered as owner (50%)
  • Hashmatullah Nasimi registered as owner (50%)

Related companies

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction